All times are listed in CEST (Central European Summer Time)

 

Displaying One Session

View
Controversy session

Is neoadjuvant chemo-immunotherapy superior to adjuvant immunotherapy?

Date
Thu, 30.03.2023
Time
08:00 - 09:00
Room
Auditorium 4
Chairs
  • L. Hendriks (Maastricht, Netherlands)
Session Description

Click Here to Vote

Controversy session

Introduction and first vote

Lecture Time
08:00 - 08:10
Speakers
  • L. Hendriks (Maastricht, Netherlands)
Session Name
Is neoadjuvant chemo-immunotherapy superior to adjuvant immunotherapy? (ID 44)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
08:00 - 09:00
Authors
  • L. Hendriks (Maastricht, Netherlands)
Controversy session

Yes

Lecture Time
08:10 - 08:30
Speakers
  • E. F. Smit (Amsterdam, Netherlands)
Session Name
Is neoadjuvant chemo-immunotherapy superior to adjuvant immunotherapy? (ID 44)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
08:00 - 09:00
Authors
  • E. F. Smit (Amsterdam, Netherlands)
Controversy session

No

Lecture Time
08:30 - 08:50
Speakers
  • H. Wakelee (Stanford, United States of America)
Session Name
Is neoadjuvant chemo-immunotherapy superior to adjuvant immunotherapy? (ID 44)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
08:00 - 09:00
Authors
  • H. Wakelee (Stanford, United States of America)
Controversy session

Second vote and conclusions

Lecture Time
08:50 - 09:00
Speakers
  • L. Hendriks (Maastricht, Netherlands)
Session Name
Is neoadjuvant chemo-immunotherapy superior to adjuvant immunotherapy? (ID 44)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
08:00 - 09:00
Authors
  • L. Hendriks (Maastricht, Netherlands)